Skip Navigation


Annals of Oncology Advance Access originally published online on February 28, 2006
Annals of Oncology 2006 17(5):801-806; doi:10.1093/annonc/mdl030
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/5/801    most recent
mdl030v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Glaus, A.
Right arrow Articles by von Moos, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glaus, A.
Right arrow Articles by von Moos, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment

A. Glaus1,*, Ch. Boehme2, B. Thürlimann2,3, T. Ruhstaller2,4, S. F. Hsu Schmitz5, R. Morant1, H. J. Senn1 and R. von Moos2

1 Tumorzentrum ZeTuP, Diagnostik, Behandlung und Prävention, St. Gallen; 2 Fachbereich, Onkologie, Department Innere Medizin, Kantonsspital St. Gallen; 3 Senologie Zentrum Ostschweiz, Kantonsspital St. Gallen; 4 Fachbereich Onkologie, Innere Medizin, Kantonsspital Münsterlingen; 5 Statistics Unit, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

* Correspondence to: Dr A. Glaus (PhD, MSc, RN), Tumorzentrum ZeTuP, Diagnostik, Behandlung und Prävention, Rorschacherstrasse 150, CH-9006 St. Gallen, Switzerland. Tel: 0041 71 243 00 43; Fax: 0041 71 243 0044; E-mail: aglaus{at}sg.zetup.ch

Background: Hormonal treatment for women with breast cancer is frequently proposed in the adjuvant as well as in the palliative setting. Therefore, many women are confronted with early menopause and prolonged oestrogen deprivation and consequently with a variety of quality of life issues, such as menopausal symptoms and fatigue.

Patients and methods: It was the aim of this study to explore the occurrence and frequency of menopausal symptoms in women with breast cancer, undergoing hormonal cancer treatment and to investigate their relationship with fatigue. A cross-sectional, quantitative approach was used in this multi-centre study. The Checklist for Patients with Endocrine Therapy (C-PET) and the International Breast Cancer Study Group (IBCSG) Linear Analogue Scales for patients with endocrine treatment were used. Descriptive statistics, as well as cluster analyses were performed.

Results: Most frequent menopausal symptoms involved hot flashes/sweats, tiredness, weight gain, vaginal dryness and decreased sexual interest. There were significant differences between the fatigued and the non-fatigued population regarding the intensity of menopausal symptoms, emotional irritability and general coping. Cluster analyses supported a menopausal symptom cluster.

Conclusions: Fatigue accompanies menopausal symptoms and an association can be expected. Methods for routine screening for menopausal symptoms, including fatigue, are suggested as a relevant research issue in women with breast cancer undergoing hormonal treatment.

Key words: breast cancer, fatigue, hormones, menopausal symptoms


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.